Global Alpha- Antitrypsin Deficiency Treatment Industry Research Report 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The Alpha%li%Antitrypsin Deficiency Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Alpha%li%Antitrypsin Deficiency Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Alpha%li%Antitrypsin Deficiency Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Alpha%li%Antitrypsin Deficiency Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Alpha%li%Antitrypsin Deficiency Treatment market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The Alpha%li%Antitrypsin Deficiency Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Alpha%li%Antitrypsin Deficiency Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Alpha%li%Antitrypsin Deficiency Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Alpha%li%Antitrypsin Deficiency Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Alpha%li%Antitrypsin Deficiency Treatment market are discussed.
The market is segmented by types:
- CT-2009
- POL-6014
- ARO-AAT
- ALNAAT-02
- Others
- Clinic
- Hospital
- Others
Finally, the report provides detailed profile and data information analysis of leading company.
- Adverum Biotechnologies, Inc.
- Digna Biotech, S.L.
- Arrowhead Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals, Inc.
- Dicerna Pharmaceuticals, Inc.
- Applied Genetic Technologies Corporation
- Grifols, S.A.
- Cevec Pharmaceuticals GmbH
- Carolus Therapeutics, Inc.
- Editas Medicine, Inc.
- Kamada Ltd.
- rEVO Biologics, Inc.
- Inhibrx
- Polyphor Ltd.
- Ionis Pharmaceuticals, Inc.
- Intellia Therapeutics, Inc.
- Sangamo BioSciences, Inc.
- ProMetic Life Sciences Inc.
- International Stem Cell Corporation
- xx data tables and xx additional tables
- An overview of global Alpha%li%Antitrypsin Deficiency Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Alpha%li%Antitrypsin Deficiency Treatment market
- Profiles of major players in the industry, including Adverum Biotechnologies, Inc., Digna Biotech, S.L., Arrowhead Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Inc......
- To study and analyze the global Alpha%li%Antitrypsin Deficiency Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Alpha%li%Antitrypsin Deficiency Treatment market by identifying its various subsegments.
- Focuses on the key global Alpha%li%Antitrypsin Deficiency Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the Alpha%li%Antitrypsin Deficiency Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Alpha%li%Antitrypsin Deficiency Treatment submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Alpha- Antitrypsin Deficiency Treatment Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 Alpha- Antitrypsin Deficiency Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT INDUSTRY OVERVIEW
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Alpha- Antitrypsin Deficiency Treatment Global Import Market Analysis
2.1.2 Alpha- Antitrypsin Deficiency Treatment Global Export Market Analysis
2.1.3 Alpha- Antitrypsin Deficiency Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 CT-2009
2.2.2 POL-6014
2.2.3 ARO-AAT
2.2.4 ALNAAT-02
2.2.5 Others
2.3 Market Analysis by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Others
2.4 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Alpha- Antitrypsin Deficiency Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
2.4.5 Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
2.4.7 Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Alpha- Antitrypsin Deficiency Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Alpha- Antitrypsin Deficiency Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Alpha- Antitrypsin Deficiency Treatment Industry
2.7.2 Alpha- Antitrypsin Deficiency Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Alpha- Antitrypsin Deficiency Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Alpha- Antitrypsin Deficiency Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region
4.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.4.1 North America Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.4.2 North America Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.5.1 Europe Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.5.2 Europe Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.6.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.6.2 Japan Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.7.1 China Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.7.2 China Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY TYPE
5.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (2015-2020)
5.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2015-2020)
5.2 CT-2009 Sales Growth Rate and Price
5.2.1 Global CT-2009 Sales Growth Rate (2015-2020)
5.2.2 Global CT-2009 Price (2015-2020)
5.3 POL-6014 Sales Growth Rate and Price
5.3.1 Global POL-6014 Sales Growth Rate (2015-2020)
5.3.2 Global POL-6014 Price (2015-2020)
5.4 ARO-AAT Sales Growth Rate and Price
5.4.1 Global ARO-AAT Sales Growth Rate (2015-2020)
5.4.2 Global ARO-AAT Price (2015-2020)
5.5 ALNAAT-02 Sales Growth Rate and Price
5.5.1 Global ALNAAT-02 Sales Growth Rate (2015-2020)
5.5.2 Global ALNAAT-02 Price (2015-2020)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2015-2020)
5.6.2 Global Others Price (2015-2020)
6 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY APPLICATION
6.1 Global Alpha- Antitrypsin Deficiency TreatmentSales Market Share by Application (2015-2020)
6.2 Clinic Sales Growth Rate (2015-2020)
6.3 Hospital Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)
7 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST
7.1 Global Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast
7.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2020-2025)
7.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Region (2020-2025)
7.2.1 North America Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue Forecast (2020-2025)
7.2.4 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT INDUSTRY KEY MANUFACTURERS
8.1 Adverum Biotechnologies, Inc.
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Adverum Biotechnologies, Inc. News
8.2 Digna Biotech, S.L.
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Digna Biotech, S.L. News
8.3 Arrowhead Pharmaceuticals, Inc.
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Arrowhead Pharmaceuticals, Inc. News
8.4 Alnylam Pharmaceuticals, Inc.
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Alnylam Pharmaceuticals, Inc. News
8.5 Dicerna Pharmaceuticals, Inc.
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Dicerna Pharmaceuticals, Inc. News
8.6 Applied Genetic Technologies Corporation
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Applied Genetic Technologies Corporation News
8.7 Grifols, S.A.
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Grifols, S.A. News
8.8 Cevec Pharmaceuticals GmbH
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Cevec Pharmaceuticals GmbH News
8.9 Carolus Therapeutics, Inc.
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Carolus Therapeutics, Inc. News
8.10 Editas Medicine, Inc.
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Editas Medicine, Inc. News
8.11 Kamada Ltd.
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Kamada Ltd. News
8.12 rEVO Biologics, Inc.
8.12.1 Company Details
8.12.2 Product Information
8.12.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 rEVO Biologics, Inc. News
8.13 Inhibrx
8.13.1 Company Details
8.13.2 Product Information
8.13.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 Inhibrx News
8.14 Polyphor Ltd.
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Polyphor Ltd. News
8.15 Ionis Pharmaceuticals, Inc.
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Ionis Pharmaceuticals, Inc. News
8.16 Intellia Therapeutics, Inc.
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Intellia Therapeutics, Inc. News
8.17 Sangamo BioSciences, Inc.
8.17.1 Company Details
8.17.2 Product Information
8.17.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.17.4 Main Business Overview
8.17.5 Sangamo BioSciences, Inc. News
8.18 ProMetic Life Sciences Inc.
8.18.1 Company Details
8.18.2 Product Information
8.18.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.18.4 Main Business Overview
8.18.5 ProMetic Life Sciences Inc. News
8.19 International Stem Cell Corporation
8.19.1 Company Details
8.19.2 Product Information
8.19.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.19.4 Main Business Overview
8.19.5 International Stem Cell Corporation News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
1 SCOPE OF THE STUDY
1.1 Alpha- Antitrypsin Deficiency Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT INDUSTRY OVERVIEW
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Alpha- Antitrypsin Deficiency Treatment Global Import Market Analysis
2.1.2 Alpha- Antitrypsin Deficiency Treatment Global Export Market Analysis
2.1.3 Alpha- Antitrypsin Deficiency Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 CT-2009
2.2.2 POL-6014
2.2.3 ARO-AAT
2.2.4 ALNAAT-02
2.2.5 Others
2.3 Market Analysis by Application
2.3.1 Clinic
2.3.2 Hospital
2.3.3 Others
2.4 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Alpha- Antitrypsin Deficiency Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
2.4.5 Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
2.4.7 Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Alpha- Antitrypsin Deficiency Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Alpha- Antitrypsin Deficiency Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Alpha- Antitrypsin Deficiency Treatment Industry
2.7.2 Alpha- Antitrypsin Deficiency Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Alpha- Antitrypsin Deficiency Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Alpha- Antitrypsin Deficiency Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region
4.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.4.1 North America Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.4.2 North America Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.5.1 Europe Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.5.2 Europe Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.6.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.6.2 Japan Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Alpha- Antitrypsin Deficiency Treatment Market Size Detail
4.7.1 China Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate (2015-2020)
4.7.2 China Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY TYPE
5.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (2015-2020)
5.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2015-2020)
5.2 CT-2009 Sales Growth Rate and Price
5.2.1 Global CT-2009 Sales Growth Rate (2015-2020)
5.2.2 Global CT-2009 Price (2015-2020)
5.3 POL-6014 Sales Growth Rate and Price
5.3.1 Global POL-6014 Sales Growth Rate (2015-2020)
5.3.2 Global POL-6014 Price (2015-2020)
5.4 ARO-AAT Sales Growth Rate and Price
5.4.1 Global ARO-AAT Sales Growth Rate (2015-2020)
5.4.2 Global ARO-AAT Price (2015-2020)
5.5 ALNAAT-02 Sales Growth Rate and Price
5.5.1 Global ALNAAT-02 Sales Growth Rate (2015-2020)
5.5.2 Global ALNAAT-02 Price (2015-2020)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2015-2020)
5.6.2 Global Others Price (2015-2020)
6 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET SEGMENT BY APPLICATION
6.1 Global Alpha- Antitrypsin Deficiency TreatmentSales Market Share by Application (2015-2020)
6.2 Clinic Sales Growth Rate (2015-2020)
6.3 Hospital Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)
7 GLOBAL ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST
7.1 Global Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast
7.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2020-2025)
7.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Region (2020-2025)
7.2.1 North America Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Alpha- Antitrypsin Deficiency Treatment Production, Revenue Forecast (2020-2025)
7.2.4 China Alpha- Antitrypsin Deficiency Treatment Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT INDUSTRY KEY MANUFACTURERS
8.1 Adverum Biotechnologies, Inc.
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Adverum Biotechnologies, Inc. News
8.2 Digna Biotech, S.L.
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Digna Biotech, S.L. News
8.3 Arrowhead Pharmaceuticals, Inc.
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Arrowhead Pharmaceuticals, Inc. News
8.4 Alnylam Pharmaceuticals, Inc.
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Alnylam Pharmaceuticals, Inc. News
8.5 Dicerna Pharmaceuticals, Inc.
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Dicerna Pharmaceuticals, Inc. News
8.6 Applied Genetic Technologies Corporation
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Applied Genetic Technologies Corporation News
8.7 Grifols, S.A.
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Grifols, S.A. News
8.8 Cevec Pharmaceuticals GmbH
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Cevec Pharmaceuticals GmbH News
8.9 Carolus Therapeutics, Inc.
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Carolus Therapeutics, Inc. News
8.10 Editas Medicine, Inc.
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Editas Medicine, Inc. News
8.11 Kamada Ltd.
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Kamada Ltd. News
8.12 rEVO Biologics, Inc.
8.12.1 Company Details
8.12.2 Product Information
8.12.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 rEVO Biologics, Inc. News
8.13 Inhibrx
8.13.1 Company Details
8.13.2 Product Information
8.13.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 Inhibrx News
8.14 Polyphor Ltd.
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Polyphor Ltd. News
8.15 Ionis Pharmaceuticals, Inc.
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Ionis Pharmaceuticals, Inc. News
8.16 Intellia Therapeutics, Inc.
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Intellia Therapeutics, Inc. News
8.17 Sangamo BioSciences, Inc.
8.17.1 Company Details
8.17.2 Product Information
8.17.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.17.4 Main Business Overview
8.17.5 Sangamo BioSciences, Inc. News
8.18 ProMetic Life Sciences Inc.
8.18.1 Company Details
8.18.2 Product Information
8.18.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.18.4 Main Business Overview
8.18.5 ProMetic Life Sciences Inc. News
8.19 International Stem Cell Corporation
8.19.1 Company Details
8.19.2 Product Information
8.19.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.19.4 Main Business Overview
8.19.5 International Stem Cell Corporation News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
LIST OF TABLES AND FIGURES
Figure Alpha- Antitrypsin Deficiency Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Alpha- Antitrypsin Deficiency Treatment Market by Regions (2019)
Table Global Market Alpha- Antitrypsin Deficiency Treatment Comparison by Regions (M USD) 2019-2025
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Type in 2019
Figure CT-2009 Picture
Figure POL-6014 Picture
Figure ARO-AAT Picture
Figure ALNAAT-02 Picture
Figure Others Picture
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Application (2019-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application in 2019
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturer (2018-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Manufacturer (2018-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units) by Region (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region (2015-2019)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region (2015-2019)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region in 2018
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Type (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Type (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type in 2019
Figure Global CT-2009 Sales Growth Rate (2015-2020)
Figure Global CT-2009 Price (2015-2020)
Figure Global POL-6014 Sales Growth Rate (2015-2020)
Figure Global POL-6014 Price (2015-2020)
Figure Global ARO-AAT Sales Growth Rate (2015-2020)
Figure Global ARO-AAT Price (2015-2020)
Figure Global ALNAAT-02 Sales Growth Rate (2015-2020)
Figure Global ALNAAT-02 Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Application (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application in 2019
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2020-2025)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Adverum Biotechnologies, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Adverum Biotechnologies, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Adverum Biotechnologies, Inc. Main Business
Table Adverum Biotechnologies, Inc. Recent Development
Table Digna Biotech, S.L. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Digna Biotech, S.L.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Digna Biotech, S.L. Main Business
Table Digna Biotech, S.L. Recent Development
Table Arrowhead Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Arrowhead Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Arrowhead Pharmaceuticals, Inc. Main Business
Table Arrowhead Pharmaceuticals, Inc. Recent Development
Table Alnylam Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Alnylam Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Alnylam Pharmaceuticals, Inc. Main Business
Table Alnylam Pharmaceuticals, Inc. Recent Development
Table Dicerna Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Dicerna Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Dicerna Pharmaceuticals, Inc. Main Business
Table Dicerna Pharmaceuticals, Inc. Recent Development
Table Applied Genetic Technologies Corporation Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Applied Genetic Technologies Corporation
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Applied Genetic Technologies Corporation Main Business
Table Applied Genetic Technologies Corporation Recent Development
Table Grifols, S.A. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Grifols, S.A.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Grifols, S.A. Main Business
Table Grifols, S.A. Recent Development
Table Cevec Pharmaceuticals GmbH Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Cevec Pharmaceuticals GmbH
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Cevec Pharmaceuticals GmbH Main Business
Table Cevec Pharmaceuticals GmbH Recent Development
Table Carolus Therapeutics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Carolus Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Carolus Therapeutics, Inc. Main Business
Table Carolus Therapeutics, Inc. Recent Development
Table Editas Medicine, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Editas Medicine, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Editas Medicine, Inc. Main Business
Table Editas Medicine, Inc. Recent Development
Table Kamada Ltd. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Kamada Ltd.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Kamada Ltd. Main Business
Table Kamada Ltd. Recent Development
Table rEVO Biologics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of rEVO Biologics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table rEVO Biologics, Inc. Main Business
Table rEVO Biologics, Inc. Recent Development
Table Inhibrx Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Inhibrx
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Inhibrx Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Inhibrx Main Business
Table Inhibrx Recent Development
Table Polyphor Ltd. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Polyphor Ltd.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Polyphor Ltd. Main Business
Table Polyphor Ltd. Recent Development
Table Ionis Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Ionis Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Ionis Pharmaceuticals, Inc. Main Business
Table Ionis Pharmaceuticals, Inc. Recent Development
Table Intellia Therapeutics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Intellia Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Intellia Therapeutics, Inc. Main Business
Table Intellia Therapeutics, Inc. Recent Development
Table Sangamo BioSciences, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Sangamo BioSciences, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Sangamo BioSciences, Inc. Main Business
Table Sangamo BioSciences, Inc. Recent Development
Table ProMetic Life Sciences Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of ProMetic Life Sciences Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table ProMetic Life Sciences Inc. Main Business
Table ProMetic Life Sciences Inc. Recent Development
Table International Stem Cell Corporation Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of International Stem Cell Corporation
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table International Stem Cell Corporation Main Business
Table International Stem Cell Corporation Recent Development
Table of Appendix
Figure Alpha- Antitrypsin Deficiency Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Alpha- Antitrypsin Deficiency Treatment Market by Regions (2019)
Table Global Market Alpha- Antitrypsin Deficiency Treatment Comparison by Regions (M USD) 2019-2025
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Type in 2019
Figure CT-2009 Picture
Figure POL-6014 Picture
Figure ARO-AAT Picture
Figure ALNAAT-02 Picture
Figure Others Picture
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Application (2019-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application in 2019
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturer (2018-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Manufacturer in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Manufacturer (2018-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturer in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Alpha- Antitrypsin Deficiency Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units) by Region (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region (2015-2019)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region (2015-2019)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region in 2018
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Alpha- Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Type (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type in 2019
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue by Type (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type in 2019
Figure Global CT-2009 Sales Growth Rate (2015-2020)
Figure Global CT-2009 Price (2015-2020)
Figure Global POL-6014 Sales Growth Rate (2015-2020)
Figure Global POL-6014 Price (2015-2020)
Figure Global ARO-AAT Sales Growth Rate (2015-2020)
Figure Global ARO-AAT Price (2015-2020)
Figure Global ALNAAT-02 Sales Growth Rate (2015-2020)
Figure Global ALNAAT-02 Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales by Application (2015-2020)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application in 2019
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2020-2025)
Table Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Alpha- Antitrypsin Deficiency Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Adverum Biotechnologies, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Adverum Biotechnologies, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Adverum Biotechnologies, Inc. Main Business
Table Adverum Biotechnologies, Inc. Recent Development
Table Digna Biotech, S.L. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Digna Biotech, S.L.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Digna Biotech, S.L. Main Business
Table Digna Biotech, S.L. Recent Development
Table Arrowhead Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Arrowhead Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Arrowhead Pharmaceuticals, Inc. Main Business
Table Arrowhead Pharmaceuticals, Inc. Recent Development
Table Alnylam Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Alnylam Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Alnylam Pharmaceuticals, Inc. Main Business
Table Alnylam Pharmaceuticals, Inc. Recent Development
Table Dicerna Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Dicerna Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Dicerna Pharmaceuticals, Inc. Main Business
Table Dicerna Pharmaceuticals, Inc. Recent Development
Table Applied Genetic Technologies Corporation Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Applied Genetic Technologies Corporation
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Applied Genetic Technologies Corporation Main Business
Table Applied Genetic Technologies Corporation Recent Development
Table Grifols, S.A. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Grifols, S.A.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Grifols, S.A. Main Business
Table Grifols, S.A. Recent Development
Table Cevec Pharmaceuticals GmbH Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Cevec Pharmaceuticals GmbH
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Cevec Pharmaceuticals GmbH Main Business
Table Cevec Pharmaceuticals GmbH Recent Development
Table Carolus Therapeutics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Carolus Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Carolus Therapeutics, Inc. Main Business
Table Carolus Therapeutics, Inc. Recent Development
Table Editas Medicine, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Editas Medicine, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Editas Medicine, Inc. Main Business
Table Editas Medicine, Inc. Recent Development
Table Kamada Ltd. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Kamada Ltd.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Kamada Ltd. Main Business
Table Kamada Ltd. Recent Development
Table rEVO Biologics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of rEVO Biologics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table rEVO Biologics, Inc. Main Business
Table rEVO Biologics, Inc. Recent Development
Table Inhibrx Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Inhibrx
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Inhibrx Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Inhibrx Main Business
Table Inhibrx Recent Development
Table Polyphor Ltd. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Polyphor Ltd.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Polyphor Ltd. Main Business
Table Polyphor Ltd. Recent Development
Table Ionis Pharmaceuticals, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Ionis Pharmaceuticals, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Ionis Pharmaceuticals, Inc. Main Business
Table Ionis Pharmaceuticals, Inc. Recent Development
Table Intellia Therapeutics, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Intellia Therapeutics, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Intellia Therapeutics, Inc. Main Business
Table Intellia Therapeutics, Inc. Recent Development
Table Sangamo BioSciences, Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of Sangamo BioSciences, Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table Sangamo BioSciences, Inc. Main Business
Table Sangamo BioSciences, Inc. Recent Development
Table ProMetic Life Sciences Inc. Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of ProMetic Life Sciences Inc.
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table ProMetic Life Sciences Inc. Main Business
Table ProMetic Life Sciences Inc. Recent Development
Table International Stem Cell Corporation Company Profile
Figure Alpha- Antitrypsin Deficiency Treatment Product Picture and Specifications of International Stem Cell Corporation
Table Alpha- Antitrypsin Deficiency Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Market Share (2018-2020)
Table International Stem Cell Corporation Main Business
Table International Stem Cell Corporation Recent Development
Table of Appendix
